Shares of Demant A/S Unsponsored ADR (OTCMKTS:WILYY - Get Free Report) saw an uptick in trading volume on Wednesday . 1,236 shares traded hands during trading, an increase of 200% from the previous session's volume of 412 shares.The stock last traded at $17.25 and had previously closed at $17.00.
Wall Street Analysts Forecast Growth
Separately, Jefferies Financial Group upgraded Demant A/S from a "hold" rating to a "strong-buy" rating in a report on Wednesday, March 18th. Two research analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, Demant A/S has an average rating of "Buy".
View Our Latest Stock Report on WILYY
Demant A/S Price Performance
The company has a quick ratio of 1.00, a current ratio of 1.36 and a debt-to-equity ratio of 1.65. The company's fifty day moving average price is $14.74 and its 200-day moving average price is $16.00.
About Demant A/S
(
Get Free Report)
Demant A/S is a Denmark-based global hearing health care company specializing in the development, manufacture and distribution of hearing solutions and audiological diagnostic instruments. The company's flagship brands include Oticon, Bernafon and Sonic, which offer a range of hearing aids designed to address various levels of hearing loss. In addition to personal hearing devices, Demant provides diagnostic equipment such as audiometers and tympanometers, supporting hearing care professionals in accurate assessment and fitting of hearing solutions.
Beyond hearing aids and diagnostics, Demant's product portfolio extends to hearing implants—cochlear and bone-anchored systems—through its Oticon Medical division.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Demant A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Demant A/S wasn't on the list.
While Demant A/S currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
